![]() |
The final Design Phase of the Biosymtec Monitor is also ready to begin, and if funding is achieved soon, devices could be available in 35 weeks for clinical trials during the Winter 2020-2021 influenza/COVID-19 season. Licensing or private-label manufacturing is available. Contact Thomas W. French, President, Biosymtec Medical, Inc. |